Hemoglobin Testing Market Size, Share, and Trends 2024 to 2034

The global hemoglobin testing market size accounted for USD 2.84 billion in 2024, grew to USD 3.04 billion in 2025 and is predicted to surpass around USD 5.64 billion by 2034, representing a healthy CAGR of 7.10% between 2024 and 2034.

  • Last Updated : November 2024
  • Report Code : 2576
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Hemoglobin Testing Market 

5.1. COVID-19 Landscape: Hemoglobin Testing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Hemoglobin Testing Market, By Product

8.1. Hemoglobin Testing Market, by Product, 2024-2034

8.1.1 Equipment

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Consumables

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Hemoglobin Testing Market, By Technology

9.1. Hemoglobin Testing Market, by Technology, 2024-2034

9.1.1. Chromatography

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Immunoassay

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Spectrophotometry

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Hemoglobin Testing Market, By End Use 

10.1. Hemoglobin Testing Market, by End Use, 2024-2034

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Clinics

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Laboratories

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Home Care Settings

10.1.4.1. Market Revenue and Forecast (2021-2034)

10.1.5. Blood Banks

10.1.5.1. Market Revenue and Forecast (2021-2034)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Hemoglobin Testing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.3. Market Revenue and Forecast, by End Use (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.5.3. Market Revenue and Forecast, by End Use (2021-2034)

Chapter 12. Company Profiles

12.1. DiaSys Diagnostic Systems

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Masimo

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. ARKRAY

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Fisher Scientific

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Bayer Medical Care

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Abbott Laboratories

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Beckman Coulter Diagnostics

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Danaher

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. F. Hoffmann-La Roche

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. ACON Laboratories

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global hemoglobin testing market size was reached at USD 2.84 billion in 2024 and it is expected to reach around USD 5.64 billion by 2034.

The global hemoglobin testing market is poised to grow at a CAGR of 7.10% from 2024 to 2034.

The major players operating in the hemoglobin testing market are DiaSys Diagnostic Systems, Masimo, ARKRAY, Fisher Scientific, Bayer Medical Care, Abbott Laboratories, Beckman Coulter Diagnostics, Danaher, F. Hoffmann-La Roche, ACON Laboratories, Diazyme Laboratories, Radiometer, EKF Diagnostics Holdings, Alere, Epinex Diagnostics, Bio-Rad Laboratories, Erba Diagnostics, Daiichi Biotech, Sysmex Corporation and Others.

The driving factors of the hemoglobin testing market are an increase in the percentage of diabetics, home diagnostic tests are projected to boost the market's expansion, increase in per capita spending on healthcare and rise in healthcare costs and awareness of blood-related illnesses.

Europe region will lead the global hemoglobin testing market during the forecast period 2023 to 2032.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client